{"nct_id":"NCT04569032","title":"A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-11-12","start_date_type":"ACTUAL","primary_completion_date":"2024-05-09","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}